Azitra grants CFO 15,015 stock options at $0.2968 exercise price

Azitra, Inc. reported an insider equity award for its Chief Financial Officer on a Form 4.

Rhea-AI Filing Summary

Azitra, Inc. reported an insider equity award for its Chief Financial Officer on a Form 4. On 12/19/2025, the CFO received stock options to buy 15,015 shares of Azitra common stock at an exercise price of $0.2968 per share. These options are exercisable through 12/19/2035.

According to the vesting terms, 25% of the shares underlying the option vest on the grant date, and the remaining balance vests in equal monthly installments over the next 36 months of continuous service. Following this transaction, the reporting person beneficially owns 15,015 derivative securities directly.

Insider Trade Summary

Grant/Award: 15,015 shares

Grant/Award 1 txn

Insider Staskey Norm

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	Stock Options (Right To Buy)	15,015	$0.00	$0.00

Holdings After Transaction: Stock Options (Right To Buy) — 15,015 contracts (Direct)

Footnotes (1)

1. F1. 25% of the shares of the Company's Common Stock subject to the Option shall vest on the date of issuance, the Vesting Commencement Date, and the remaining balance shall vest in equal monthly installments over the next 36 months of continuous service thereafter.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Azitra (AZTR) disclose in this Form 4?

Azitra disclosed that its Chief Financial Officer received stock options for 15,015 shares of common stock at an exercise price of $0.2968 per share on 12/19/2025.

Who is the reporting person in the Azitra (AZTR) Form 4 filing?

The reporting person is Azitra, Inc.’s Chief Financial Officer, who filed the Form 4 as a single reporting person.

What are the vesting terms of the 15,015 Azitra (AZTR) stock options?

25% of the common stock subject to the option vests on the issuance date, and the remaining shares vest in equal monthly installments over the next 36 months of continuous service.

When do the newly granted Azitra (AZTR) stock options expire?

The stock options granted on 12/19/2025 have an expiration date of 12/19/2035.

How many derivative securities does the Azitra (AZTR) CFO own after this transaction?

Following the reported transaction, the CFO beneficially owns 15,015 derivative securities (stock options) directly.

What type of security underlies the Azitra (AZTR) stock options reported?

The options are stock options with a right to buy Azitra common stock, covering 15,015 shares in total.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 12/22/2025 - 05:28 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Staskey Norm

(Last) (First) (Middle)

21 BUSINESS PARK DRIVE

(Street)

BRANFORD CT 06405

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Azitra, Inc. [ AZTR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
12/19/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options (Right To Buy)	$0.2968	12/19/2025		A		15,015		(1)	12/19/2035	Common Stock	15,015	$0.00	15,015	D

Explanation of Responses:

1. 25% of the shares of the Company's Common Stock subject to the Option shall vest on the date of issuance, the Vesting Commencement Date, and the remaining balance shall vest in equal monthly installments over the next 36 months of continuous service thereafter.

	/s/ Norman Staskey	12/22/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.